Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,278 total articles
Krystal Biotech is a commercial-stage gene-therapy specialist that is generating positive earnings, strong free cash flow, and multiple late-stage clinical readouts over the next 12 months. The stock is trading above its recent 52-week high, but the company's profitable base (EPS $7.63; FCF $237M) and large addressable market in rare dermatologic a…
Nordic American Tankers (NAT) has delivered on the thesis that drove my bullish stance last year: stronger tanker market conditions, fleet optimization and steady cash returns. At $6.41 the stock offers a compelling combination of yield and momentum. I lay out an actionable mid-term trade with entry, stop and target, plus catalysts and balanced ris…
I am upgrading American Airlines (AAL) to Buy. The stock is trading at a compelling implied enterprise valuation, recent corporate sustainability deals and event-driven demand should support revenue recovery, and technicals are neutral-to-constructive. This is a long-term trade (180 trading days) with a clear stop and target that balances upside op…
Healthcare Services Group (HCSG) has turned profitable growth into cash flow and shareholder returns. With $1.84B of revenue in 2025, free cash flow of $148.5M and an active buyback program, the stock at $23.74 offers a favorable risk-reward for a mid-term trade. Operational improvements in Environmental Services and Dietary, plus a fresh $75M repu…
Applied Digital reported a breakout operational quarter through campus deliveries and scale wins, turning a narrative of potential into tangible AI capacity. The stock is richly valued today, but the combination of repeatable execution (175 MW live at Polaris Forge 1), a contracted 400 MW pipeline, and near-term financing to accelerate buildout jus…
Synopsys (SNPS) is trading near the low end of its 52-week range after an earnings-driven pullback. The company sits on a sizable services/IP + design automation franchise amplified by the Ansys acquisition and enterprise AI toolchains from partners like NVIDIA. With free cash flow of roughly $2.63B, a healthy balance sheet and an upcoming Septembe…
Navios Maritime Partners (NMM) has been using capital markets and distributions to shore up its balance sheet while trading near 52-week highs. Recent bond issuance, recurring cash distributions and what management frames as shareholder-friendly actions create a favorable risk/reward for a mid-term long. This trade idea lays out a clear entry, stop…
Select Water Solutions (WTTR) offers a differentiated asset base - built water infrastructure, service logistics and chemical supply - that lets it extract multiple revenue streams from the same water flows. At $18.01 the stock is a speculative but actionable long for a position trade: the combination of recurring service revenues, a growing lithiu…
Petrobras reported a strong Q2 trading backdrop, but the more interesting trade is a mid-term long that captures accelerating offshore activity in the Santos Basin, a 5.5% yield and a valuation that still looks cheap at roughly 6x earnings. Enter near the market, protect with a below-support stop and target an upside toward the 52-week range as cat…
AppLovin is executing at scale: high-teens to double-digit growth in revenue, expanding margins, heavy cash generation and active buybacks. The market has punished the stock on macro and narrative worries, creating a tactical long opportunity. This trade idea lays out entry, stop and a $710 target tied to analyst upside and fundamental re-rating ca…
AAR (AIR) has shown the first clear signs of backlog translating into recurring revenue and profit. Strong recent quarters, accelerating sales, and improving margins—combined with a healthy balance sheet and a growing MRO market—support a tactical long. This trade idea lays out entry, stop, and tiered targets with risk controls and catalysts to wat…
We upgrade Kingsoft Cloud (KC) to BUY with a $22 target. Market cap is $3.22B and recent data show accelerating AI cloud growth, improving margins and bullish technicals. A capital-efficient shift to GPU-centric AI engines and tighter cost control should drive EBITDA leverage; the trade is actionable ahead of the Q2 2026 print with a clear entry, s…
Luckin Coffee (LKNCY) is a different animal than Starbucks. Fast-store expansion, technology-first unit economics and strong customer growth give the stock room to appreciate from $32.09. I recommend a tactical long: enter at $32.00, stop at $29.00, target $39.00 over a swing window as the market re-rates growth to profitability.
Kraken Robotics (KRKNF) designs sonar, subsea batteries and underwater robotic systems that are landing repeat naval and infrastructure contracts. With a $1.64B market cap and accelerating revenue (Q1 revenue jumped to $21M, +175% YoY), the story is now about converting program wins into scale. This is a tactical long: enter near $4.25, protect cap…
Coherent (COHR) is a prime supplier of optical components, lasers and engineered materials to the AI and data-center upgrade cycle. Fundamentals and secular demand remain intact, but the stock has suffered a heavy pullback on broader multiple compression and volatile flows. We keep a Buy stance because the long-term thesis still works; the trade he…
AnaptysBio has cleared a meaningful procedural hurdle in its fight with Tesaro/GSK and has moved the litigation closer to a definitive outcome. With a $1.54B market cap, modest free cash flow and a compact float, the stock is positioned for a sharp re-rate if Anaptys secures reversion or damages tied to Jemperli royalties. This trade idea lays out …
Gentex (GNTX) is a cash-flowing, low-debt auto supplier trading at mid-teens earnings multiples and an EV/EBITDA under 8. For traders willing to accept leverage and a wider stop, a mid-term swing long at $24.05 targets $28.50 with a $20.80 stop - a plan that leans on solid fundamentals, recent sales uplift from acquisition, and high short interest …
Interface is executing: steady top-line growth, margin recovery, and cash generation combined with product innovation (LVT, Intersept) support a tactical long. Valuation is reasonable at roughly $2.04B market cap and a mid-teens P/E. Trade plan below sets an entry at $34.45, a stop at $31.50, and a near-term target at $38.00 for a mid-term (45 trad…
Navios Maritime Partners has captured meaningful tanker arbitrage upside and the stock is trading near its 52-week high. With a market cap of about $2.46B and a P/E of ~6.3, the company looks cheap on headline metrics, but the next leg higher depends on capital allocation: debt paydown vs buybacks vs distributions. Our trade sets a clear entry at $…
Novavax is a beaten-down vaccine specialist trading near oversold technicals and a sub-$1.3B enterprise value. Recent adjuvant licensing and sector momentum give a plausible re-rating catalyst over the next 45 trading days, but inconsistent revenue, cash burn, and heavy short interest make this a pragmatic, risk-managed trade.
Uber fell into a deep pullback recently; at current levels the company trades at mid-teens earnings multiple with $9.1B in free cash flow and a $144B market cap. I’m adding to my position with a position-sized buy, a tight stop below the recent low, and a target that prices in recovery in mobility and delivery margins. This is a trade for investors…
Coca-Cola (KO) reported strong Q2 results and raised full-year guidance, hitting an all-time high intraday. For traders looking to shift out of headline-driven tech volatility, KO offers a liquid, dividend-paying defensive play with room to run on continued volume recovery and margin tailwinds. This idea lays out a concrete entry, stop and target f…
argenx's VYVGART franchise is entering a new phase after broad FDA label expansion and encouraging CIDP data. With a $56.9B market cap, a clear path to multi-billion dollar sales, and improving trial dynamics across neuromuscular indications, the risk/reward favors buying weakness. This trade idea lays out an entry, stop, and target for a long-term…
HubSpot has been hammered in 2026 amid broad SaaS volatility and cornered narratives around AI. The business is still growing 23% year-over-year, generates ~$743M of free cash flow and serves ~300,000 customers. At $238 the stock is a tactical buying opportunity for a 180-trading-day recovery to healthier multiples. Trade plan included.
Telkom Indonesia (TLKM) looks poised to re-rate after a string of positive operational updates: steady broadband subscriber growth, faster-than-expected migration to fixed broadband and 5G-capable customers, and clearer capital allocation priorities from management. We move to a bullish stance and recommend a tactical long with defined entry, stop,…
